p. 1037 - 1043
(2000)p. 1215
(1982)p. 749 - 751
(2003)p. 377 - 380
(1986)p. 5471 - 5475
(2021/07/26)p. 9204 - 9207
(2021/09/20)p. 3563 - 3566
(2020/04/03)p. 15333 - 15346
(2019/01/03)p. 294 - 307
(2018/11/26)(2017/02/09)
p. 746 - 762
(2016/08/18)(2017/02/02)
p. 381 - 388
(2016/01/12)p. 81395 - 81398
(2015/10/06)p. 543 - 550
(2015/04/27)(2016/10/07)
p. 17467 - 17472
(2015/10/19)p. 11110 - 11113
(2014/10/15)p. 91 - 96
(2014/06/24)p. 3635 - 3642
(2014/07/08)p. 6752 - 6759
(2013/01/15)p. 5613 - 5614
(2010/10/21)p. 254 - 260
(2010/03/26)p. 2904 - 2907
(2010/09/30)p. 1371 - 1377
(2010/10/03)p. 965 - 969
(2008/09/17)p. 5034 - 5036
(2008/09/18)p. 2657 - 2660
(2007/10/03)(2010/02/09)
p. 2993 - 2999
(2007/10/03)p. 6835 - 6836
(2007/10/03)p. 4711 - 4722
(2007/10/02)p. 599 - 605
(2007/10/02)N,N-bis(tosylmethyl)benzylamine
1-benzylaziridine
ethylene dibromide
1,4-dioxane
1,4-bis-(2,2-bis-ethoxycarbonyl-1-phenyl-ethyl)-piperazine